Literature DB >> 25818496

Prevention of knee osteoarthritis in overweight females: the first preventive randomized controlled trial in osteoarthritis.

Jos Runhaar1, Marienke van Middelkoop2, Max Reijman3, Sten Willemsen4, Edwin H Oei5, Dammis Vroegindeweij6, Gerjo van Osch3, Bart Koes2, Sita M A Bierma-Zeinstra7.   

Abstract

BACKGROUND: With accumulating knowledge on osteoarthritis development, the next step is to focus on possibilities for primary prevention.
METHODS: In a 2 × 2 factorial design, the effects of a diet-and-exercise program and of oral glucosamine sulfate (double blind and placebo-controlled) on the incidence of knee osteoarthritis were evaluated in a high-risk group of 407 middle-aged women with a body mass index ≥ 27 kg/m(2) without clinical signs of knee osteoarthritis at baseline (ISRCTN 42823086). Primary outcome was the incidence of knee osteoarthritis, defined as Kellgren & Lawrence grade ≥ 2, joint space narrowing of ≥ 1.0 mm, or clinical knee osteoarthritis (clinical and radiographic American College of Rheumatology criteria) after 2.5 years.
RESULTS: After 2.5 years, only 10% of all subjects were lost to follow-up, and 17% of all knees showed incident knee osteoarthritis. Accounting for the significant interaction between the interventions, no significant main effect of either intervention was found. Independently, both interventions alone showed indications of reduced knee osteoarthritis incidence (odds ratio [OR] 0.69; 95% CI, 0.39-1.21 for the diet-and-exercise program and OR 0.60; 95% CI, 0.31-1.12 for the glucosamine intervention). These effects were neutralized in subjects receiving both interventions (OR 0.97; 95% CI, 0.55-1.71).
CONCLUSIONS: No significant main effects of the diet-and-exercise program and of glucosamine sulfate were found on incident knee osteoarthritis. Nevertheless, this trial provides valuable insights for future trial design for preventive osteoarthritis studies.
Copyright © 2015 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Glucosamine; Knee osteoarthritis; Overweight; Prevention; Randomized controlled trial; Weight loss

Mesh:

Substances:

Year:  2015        PMID: 25818496     DOI: 10.1016/j.amjmed.2015.03.006

Source DB:  PubMed          Journal:  Am J Med        ISSN: 0002-9343            Impact factor:   4.965


  17 in total

Review 1.  Can we prevent OA? Epidemiology and public health insights and implications.

Authors:  Jos Runhaar; Yuqing Zhang
Journal:  Rheumatology (Oxford)       Date:  2018-05-01       Impact factor: 7.580

2.  Intentional Weight Loss in Overweight and Obese Patients With Knee Osteoarthritis: Is More Better?

Authors:  Stephen P Messier; Allison E Resnik; Daniel P Beavers; Shannon L Mihalko; Gary D Miller; Barbara J Nicklas; Paul deVita; David J Hunter; Mary F Lyles; Felix Eckstein; Ali Guermazi; Richard F Loeser
Journal:  Arthritis Care Res (Hoboken)       Date:  2018-11       Impact factor: 4.794

3.  Randomized Controlled Trial of an Educational Intervention Using an Online Risk Calculator for Knee Osteoarthritis: Effect on Risk Perception.

Authors:  Elena Losina; Griffin L Michl; Karen C Smith; Jeffrey N Katz
Journal:  Arthritis Care Res (Hoboken)       Date:  2017-07-10       Impact factor: 4.794

4.  Editorial: Bone and Cartilage Diseases-The Role and Potential of Natural Products.

Authors:  Daohua Xu; Longhuo Wu; Qian Chen
Journal:  Front Pharmacol       Date:  2022-05-26       Impact factor: 5.988

5.  Cross-Cohort Automatic Knee MRI Segmentation With Multi-Planar U-Nets.

Authors:  Mathias Perslev; Akshay Pai; Jos Runhaar; Christian Igel; Erik B Dam
Journal:  J Magn Reson Imaging       Date:  2021-12-17       Impact factor: 5.119

Review 6.  Effects of weight loss interventions for adults who are obese on mortality, cardiovascular disease, and cancer: systematic review and meta-analysis.

Authors:  Chenhan Ma; Alison Avenell; Mark Bolland; Jemma Hudson; Fiona Stewart; Clare Robertson; Pawana Sharma; Cynthia Fraser; Graeme MacLennan
Journal:  BMJ       Date:  2017-11-14

7.  Resveratrol ameliorates inflammatory damage and protects against osteoarthritis in a rat model of osteoarthritis.

Authors:  Yulong Wei; Jie Jia; Xin Jin; Wei Tong; Hongtao Tian
Journal:  Mol Med Rep       Date:  2017-11-13       Impact factor: 2.952

8.  Associations of clinical outcomes and MRI findings in intra-articular administration of autologous adipose-derived stem cells for knee osteoarthritis.

Authors:  Junya Higuchi; Ryota Yamagami; Takumi Matsumoto; Tomohiro Terao; Keita Inoue; Shinsaku Tsuji; Yuji Maenohara; Tokio Matsuzaki; Ryota Chijimatsu; Yasunori Omata; Fumiko Yano; Sakae Tanaka; Taku Saito
Journal:  Regen Ther       Date:  2020-05-25       Impact factor: 3.419

9.  Development and feasibility of a personalized, interactive risk calculator for knee osteoarthritis.

Authors:  Elena Losina; Kristina Klara; Griffin L Michl; Jamie E Collins; Jeffrey N Katz
Journal:  BMC Musculoskelet Disord       Date:  2015-10-22       Impact factor: 2.362

10.  Maximum lifetime body mass index is the appropriate predictor of knee and hip osteoarthritis.

Authors:  Sabine Patricia Singer; Dietmar Dammerer; Martin Krismer; Michael C Liebensteiner
Journal:  Arch Orthop Trauma Surg       Date:  2017-10-27       Impact factor: 3.067

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.